肌酸 Creatine × 帕金森氏症

結論:主流反證據

高品質 RCT 證據明確指向「無效」:2017 BMC Neurology 統合分析(5 RCT、n=1339)與 2014 Cochrane 系統性回顧均顯示肌酸對 UPDRS 總分、運動功能、ADL、生活品質均無顯著改善;NIH NET-PD LS-1 大型試驗(10 g/日、5 年、雙盲安慰劑對照)於 2013 年因 futility 提前終止。

D 🔴 D 反證據 主流反證據 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 💊 檢驗 / 藥物交互作用

高品質 RCT 證據明確指向「無效」:2017 BMC Neurology 統合分析(5 RCT、n=1339)與 2014 Cochrane 系統性回顧均顯示肌酸對 UPDRS 總分、運動功能、ADL、生活品質均無顯著改善;NIH NET-PD LS-1 大型試驗(10 g/日、5 年、雙盲安慰劑對照)於 2013 年因 futility 提前終止。

Michael J. Fox 基金會與 MDS 實證回顧亦明確不推薦肌酸用於 PD。

Mayo Clinic 另警告肌酸 + 每日 >300 mg 咖啡因可能加速疾病進展。

整體屬於 D 級(against)— 證據不僅不足,而是大型 RCT 證實無效並具特定安全顧慮。

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.27
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
D · 主流反證據
信心度
83%
證據方向一致性高
證據層級
E1
Cochrane 高品質系統性回顧/統合分析

各層「支持此療效」的程度

分數越低=該層越不支持
L2 PubMed原始文獻
0.20
L3 機轉生理合理性
0.20
L11 AI 複核獨立判讀
0.30
L5 臨床機構權威立場
0.32
L1 Examine國際基準
0.50
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.269
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial (NET-PD LS-1)
PMID: 25668262 2015 RCT (double-blind) n = 1,741
結論:The trial was terminated early for futility: at the planned interim analysis (n=955) the global statistical test was t1865.8 = -0.75 (2-sided P = .45), with mean summed ranks of 2360 (placebo) vs 2414 (creatine) and no detectable difference in adverse events.
🟢 高品質 政府資助 效應量:Global test t1865.8 = -0.75, P = .45 (null); mean summed ranks placebo 2360 (95% CI 2249-2470) vs creatine 2414 (95% CI 2304-2524)
前往 PubMed
Creatine for Parkinson's disease (Cochrane Systematic Review)
PMID: 24934384 2014 Cochrane Review n = 194
結論:Pooling 2 RCTs (n=194) found no clear effect on motor function (MD -0.26, 95% CI -4.39 to 3.88) or ADL (MD 0.37, 95% CI -1.28 to 2.02), both low-quality evidence, with higher gastrointestinal side-effect rates at 2-year follow-up.
學術資助 效應量:Motor function MD -0.26 (95% CI -4.39 to 3.88); ADL MD 0.37 (95% CI -1.28 to 2.02); low-quality evidence
前往 PubMed
The effectiveness of creatine treatment for Parkinson's disease: an updated meta-analysis of randomized controlled trials
PMID: 28577542 2017 統合分析 n = 1,339
結論:Across 5 RCTs (n=1339) there were no significant differences between creatine and control in total, mental, ADL or motor UPDRS scores, with only a marginal improvement seen on the Schwab & England Scale.
學術資助 效應量:No significant difference on total/mental/ADL/motor UPDRS; isolated improvement on Schwab & England Scale only
前往 PubMed
Meta-Analysis of Creatine for Neuroprotection Against Parkinson's Disease
PMID: 27823574 2017 統合分析 n = 1,935
結論:Pooling 3 RCTs (n=1935) the overall effect favored neither group on UPDRS total (MD 1.07, 95% CI -3.38 to 1.25), UPDRS III (MD 0.62, 95% CI -2.27 to 1.02), UPDRS II (MD 0.03) or UPDRS I (MD 0.03), so current evidence does not support creatine for neuroprotection against PD.
🟠 品質有限 學術資助 效應量:UPDRS total MD 1.07 (95% CI -3.38 to 1.25); UPDRS III MD 0.62 (95% CI -2.27 to 1.02); all CIs cross zero
前往 PubMed

L4a US FDA
支持
FDA has no questions 來源↗
L4b EU EFSA
支持
cause and effect relationship has been established 來源↗
L4c UK NHS
未表態
Supplements containing creatine are widely used by athletes to improve performance 來源↗
L4d TW TFDA / 衛福部
未表態
— 本適應症無對應資料
L4e WHO
未表態
— 本適應症無對應資料

L5a NIH Office of Dietary Supplements
支持
May increase strength, power 來源↗
L5b Mayo Clinic
謹慎
In one large study of people with Parkinson's disease who took creatine, those who consumed more than 300 mg of caffeine a day had faster progression of Parkinson's disease. More research is needed. 來源↗
L5c Cleveland Clinic
謹慎
Neurodegenerative diseases, such as muscular dystrophy, Parkinson's disease and Huntington's disease [may benefit from creatine supplements]. Studies suggest that creatine supplements may help brain function in people 60 and older. This includes: Short-term memory. Reasoning. Neuroprotection (keeping groups of nerve cells safe from injury or damage). 來源↗
L5d Harvard Health
謹慎
Some small studies have suggested that creatine might be helpful for those with a few diseases that afflict older people, such as heart failure and Parkinson's disease. 來源↗
L5e Specialty Society (condition-mapped)
反對
In Parkinson's, researchers have investigated certain supplements, such as creatine, coenzyme Q, inosine and vitamin E. (Unfortunately none demonstrated benefit.) 來源↗

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

台灣 PTT、Dcard、Mobile01 等社群關於肌酸的討論幾乎全部集中於健身、增肌、運動表現,並未見到一般使用者將肌酸與帕金森氏症(巴金森症)做連結的心得或推薦;帕金森氏症相關社群討論多聚焦於藥物(如左旋多巴)、深部腦刺激手術與門診推薦,幾乎無人提及補充肌酸作為輔助。

💬社群實感

資料不足

破解迷思 社群最常見的 3 個誤解
事實誤以為肌酸只是健身族用品,與神經疾病無關
事實誤以為肌酸會傷腎,因此帕金森長者不敢嘗試
事實誤以為肌酸吃了會水腫、變胖,不適合年長者
🩹 社群通報的副作用
  • 腸胃不適、乾嘔
  • 體重短期上升(水分滯留)
  • 口渴、需大量補水
🏷️ 社群熱議品牌

依論壇被提及頻率,非銷售或品質排序。

  • MyProtein
  • Optimum Nutrition (ON)
  • Muscletech
  • 果果家 GuoGuo
  • BSN
  • Cyclone

⚠️ 列出僅代表「TW 社群討論度高」,不代表本站推薦或背書。本站不販售任何產品、無導購連結。

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

協助短時間高強度運動表現

代表來源 ↗
L10b · TFDA 法定身份 官方認定

肌酸補充基本上是安全的

來源 ↗

  • Levodopa / Carbidopa-Levodopa
  • 規律運動 (有氧 + 阻力)
PMID 可查證引用皆附 NCBI PubMed 原始連結
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-09 claim_version: v11 engine_version: v1.0 claim_id: CLM-COND-parkinson-INT-creatine-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-parkinson-INT-creatine-001/",
  "datePublished": "2026-06-09",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "肌酸能改善帕金森氏症",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 1,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🔴 D 反證據"
  }
}